Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

OPM's OsteoFab® 3D printed PEKK Technology in Study Published in Nature

Research Study by McGill University(1) Definitively Establishes Suitability of 3D Printed PEKK Scaffolds as Integral Component for Regenerating Critical-sized Bone Defects


News provided by

Oxford Performance Materials

Jun 20, 2019, 08:30 ET

Share this article

Share toX

Share this article

Share toX


SOUTH WINDSOR, Conn., June 20, 2019 /PRNewswire-PRWeb/ -- Oxford Performance Materials, a pioneer in advanced materials science and high-performance additive manufacturing (HPAM®), announced today exciting results of a McGill University research study recently published in Nature(2) that establish a definitive link between OPM's 3D printed PEKK material and bone regeneration. In vitro results of the study demonstrate the ability of human synovial fluid mesenchymal stem cells to attach, proliferate, and differentiate on PEKK scaffolds, and in vivo results show strong evidence of new bone formation.

OPM has long had strongly indicative data that its' OsteoFab 3D printed PEKK technology has a highly desirable bone response. Early in vitro studies (circa 2010) had indicated a positive and exciting cellular response to 3D printed PEKK when compared to control materials, which prompted further investigation. Subsequent in vivo studies that examined tissue response to 3D printed PEKK implants in an osseous environment (rabbit model, circa 2013) showed that native PEKK material supported bone apposition. Interestingly, and unlike commonly used PEEK material, OsteoFab 3D printed PEKK showed no observable immunological rejection and no increase in inflammatory response cells. What was attributed to PEKK's unique chemistry and the inherent surface roughness of OsteoFab 3D printed PEKK has since led to a number of additional studies and clinical applications.

Unlike commonly used PEEK material, OsteoFab® 3D printed PEKK showed no observable immunological rejection and no increase in inflammatory response cells

Post this

Shifting from studying the bulk implant material to latticed, scaffold structures, OsteoFab 3D printed PEKK scaffolds were similarly examined in in vitro and in vivo experiments. In 2014, a funded research study demonstrated the successful growth of bone marrow cells on 3D printed PEKK scaffolds and since then, a number of publications have examined the use of mesenchymal stem cells (autologous, adipose-derived, and human synovial fluid-derived) on PEKK scaffolds in critical sized defects. In 2016, Adamzyk et al.(3) studied the use of PEKK scaffolds with autologous mesenchymal stem cells in a sheep calvarial defect model and found that 3D printed PEKK scaffolds allowed for the adherence, growth, and osteogenic differentiation of human and ovine stem cells, with considerable amounts of newly formed bone in all PEKK groups. In 2017, Roskies et al.(4) similarly studied 3D printed PEKK scaffolds with adipose-derived stem cells for the reconstruction of critical sized mandibular defects. This group determined that the PEKK scaffolds presented a promising solution to improve bone-implant interfaces and biomechanical attributes of implanted materials.

Later in 2017, in a paper published by Wang et al. in the International Journal of Nanomedicine(5) , OsteoFab 3D printed PEKK was also shown to possess antibacterial properties when compared to conventional PEEK material. This in vitro study indicated decreased adhesion and growth of common bacterial strains on the rough PEKK surface when compared to a PEEK control, suggesting the need for additional studies of 3D printed PEKK in a wide range of antibacterial orthopedic applications.

With this body of work and the functionalizing of 3D printed PEKK scaffolds culminating into the recent publication in Nature, one fact has remained constant; that regardless of stem cell seeding or defect model, native 3D printed PEKK test groups have demonstrated bone apposition, bone ingrowth, and improved biomechanical properties, making OsteoFab 3D printed PEKK a more desirable and functional implant material.

With the amount of literature growing around the use and application of OsteoFab 3D printed PEKK technology, the clinical possibilities are also growing. Since 2013, OPM has been manufacturing patient-specific cranial and facial implant devices that have been distributed world-wide. In addition to over 2,000 craniomaxillofacial implants, OPM has also 3D printed tens of thousands of spinal implants under a number of 510(k) clearances. As the need for clinically robust, all-encompassing solutions grows, OsteoFab® 3D printed PEKK is there to meet the demand.

About Oxford Performance Materials, Inc.
Oxford Performance Materials was founded in 2000 to exploit and commercialize the world's highest performing thermoplastic, PEKK (poly-ether-ketone-ketone). OPM's Materials business has developed a range of proprietary, patented technologies for the synthesis and modification of a range of PAEK polymers that are sold under its OXPEKK® brand for biomedical, aerospace, and industrial applications. The Company is a pioneer in 3D printing. OPM Biomedical's OsteoFab® technology is in commercial production in numerous orthopedic implant applications, including cranial, facial and spinal devices. OPM is the first and only company to receive FDA 510(k) clearance to manufacture 3D printed patient-specific polymeric implants, and has five 510(k) clearances in its portfolio. OPM Industrial produces 3D printed OXFAB® production parts for highly demanding applications in the energy, transportation and semiconductor markets. OXFAB® structures offer significant weight, cost, and time-to-market reductions that are defined in a set of specified performance attributes in the exhaustive OPM B-Basis database, developed in conjunction with NASA. For more information, please visit: http://www.oxfordpm.com

References
1.    Lin, Y., Umebayashi, M., Abdallah, M., Dong, G., Roskies, M., & Zhao, Y. et al. (2019). Combination of polyetherketoneketone scaffold and human mesenchymal stem cells from temporomandibular joint synovial fluid enhances bone regeneration. Scientific Reports, 9(1). doi: 10.1038/s41598-018-36778-2
2.    Scientific Reports 9, Article number: 472 (2019)
3.    Adamzyk, C., Kachel, P., Hoss, M., Gremse, F., Modabber, A., & Hölzle, F. et al. (2016). Bone tissue engineering using polyetherketoneketone scaffolds combined with autologous mesenchymal stem cells in a sheep calvarial defect model. Journal Of Cranio-Maxillofacial Surgery, 44(8), 985-994. doi: 10.1016/j.jcms.2016.04.012
4.    Roskies, M., Fang, D., Abdallah, M., Charbonneau, A., Cohen, N., & Jordan, J. et al. (2017). Three-dimensionally printed polyetherketoneketone scaffolds with mesenchymal stem cells for the reconstruction of critical-sized mandibular defects. The Laryngoscope, 127(11), E392-E398. doi: 10.1002/lary.26781
5.    Wang, M., Bhardwaj, G., & Webster, T. (2017). Antibacterial properties of PEKK for orthopedic applications. International Journal Of Nanomedicine, Volume 12, 6471-6476. doi: 10.2147/ijn.s134983

SOURCE Oxford Performance Materials

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.